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Abstract
Background: We examined whether a vascular smooth muscle cell (SMC) sheet is effective in the treatment of a
rat myocardial infarction (MI) model.
Methods: We examined the effect of SMC sheet on the cardiac function and cardiac remodeling in a rat MI model
in comparison with their effect of dermal fibroblast (DFB) sheet in vivo. Furthermore, we estimated the apoptosis
and secretion of angiogenic factor of SMC under hypoxic condition in comparison with DFB. Seven days after MI,
monolayer cell sheets were transplanted on the infarcted area (SMC transplantation group, SMC-Tx; DFB transplantation
group, DFB-Tx; no cell sheet transplantation group, Untreated; neither MI nor cell sheet transplantation group, Sham).
We evaluated cardiac function by echocardiogram, degree of cardiac remodeling by histological examination, and
secretion of angiogenic growth factor by enzyme immunoassay.
Results: Twenty-eight days after transplantation, SMC-Tx showed the following characteristics compared with the
other groups: 1) significantly greater fractional area shortening (SMC-Tx, 32.3 ± 2.1 %; DFB-Tx, 23.3 ± 2.1 %; untreated,
25.1 ± 2.6 %), 2) suppressed left ventricular dilation, smaller scar expansion, and preserved wall thickness of the area at
risk and the posterior wall, 3) decreased fibrosis, preserved myocardium in the scar area, and greater number of
arterioles in border-zone, 4) tight attachment of SMC sheets on the scarred myocardium, and less apoptotic cell
death. In in vitro experiments, SMCs secreted higher amounts of basic fibroblast growth factor (SMC, 157.7 ± 6.4 pg/ml;
DFB, 3.1 ± 1.0 pg/ml), and showed less apoptotic cell death under hypoxia.
Conclusions: Our results illustrate that transplantation of SMC sheets inhibited the progression of cardiac remodeling
and improve cardiac function. These beneficial effects may be due to superior SMC survival.
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Background
Severe cardiac dysfunction after myocardial infarction
(MI) impairs the quality of life and leads to poor disease
prognosis. Recently, cell transplantation using several
cell sources can prevent cardiac dysfunction after MI
and dilated cardiomyopathy (DCM) in animal models
and in clinical trials: bone marrow mononuclear cells
[1], mesenchymal stem cells [2] and skeletal myoblasts
[3]. The high attrition rate of transplanted cells [4], due
to cell injury through isolation procedure, exposure to
ischemic conditions, apoptosis, inflammation, and im-
munological rejection, is the major limitation of cell
transplantation. Increasing the transplanted cell survival
rate is paramount to improve the therapeutic potential
of this method, since sustained paracrine effects from
grafted cells is considered to be a principal mechanism
of cell therapy [5].
Cell sheet technology has been developed using
temperature-responsive culture dishes. Using this method,
cells are harvested from dishes easily by a simple tem-
perature reduction [6]. Recovered cells consist of intact
sheets along with the extracellular matrix. Cell sheet
methodology improves cell survival compared to cell in-
jection methods [7]. Skeletal myoblast and adipose-tissue
derived mesenchymal stem cell sheets attenuate cardiac
remodeling in rat MI models [8, 9]. Recently, the autolo-
gous skeltal myoblast cell sheets became commercially
available for the treatment of ischemic cardiomyopathy in
Japan [10]. Ideal characteristics of cells for cell transplant-
ation into post MI tissue are: secretion of angiogenic fac-
tors, ease of culture and survival in the host myocardium.
Smooth muscle cells (SMCs) secrete several angiogenic
factors, such as basic fibroblast growth factor (bFGF) [11],
vascular endothelial cell growth factor (VEGF) [12], and
hepatocyte growth factor (HGF) [13]; thus a paracrine
angiogenic effect is expected. Additionally, it is easy to
culture and maintain SMCs compared to other cell
types such as endothelial cells or endothelial progeni-
tor cells [14]. SMC transplantation has been conducted
in rat MI [4, 15–17] and hind limb ischemia models
[13]. However, SMC sheet transplantation for MI has
not yet been investigated. In the present study, we
examine whether a SMC sheet is effective in the pre-
vention of cardiac dysfunction and remodeling in a rat
MI model.
Methods
We examined the effect of SMC sheet on the cardiac
function and cardiac remodeling in a rat MI model in
comparison with their effect of DFB sheet in vivo. Fur-
thermore, we estimated the apoptosis and secretion of
angiogenic factor of SMC under hypoxic condition in
comparison with DFB.
Experimental animals
Adult male syngenic Lewis rats were obtained from
Japan SLC, Inc (Hamamatsu, Japan). Animals weighing
200 to 250 g served as cell donors and recipients. The
experimental protocols were approved by the Institutional
Animal Care and Use Committee, Faculty of Medicine,
Tottori University, and conform to the Guide for the Care
and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No.
85–23, revised 1996). All the procedures were per-
formed in accordance with the Tottori University animal
care guidelines.
Myocardial infarction
Rats were anesthetized with inhalation of Isoflurane
(Abbott Japan, Osaka, Japan), followed by intubation and
mechanical ventilation (SN-480-7, Shinano, Tokyo, Japan)
at a rate of 60 cycles per minutes with a tidal volume
of 2 mL under room air supplemented with oxygen
(2 L/min) and 1–2.5 % Isoflurane. The heart was ex-
posed through a 2 cm left thoracotomy, and an anterior
myocardial infarction was created by ligation of the
proximal coronary artery [left anterior descending artery
(LAD)] as previously described [18]. After LAD ligation,
the animals recovered from the operation and were
given Procaine Penicillin G (Procaine Penicillin G sol,
Kawasakimitaka, Kawasaki, Japan) for three days after
the operation.
Preparation of cell sheets
SMCs were isolated from rat aortas. Briefly, descending
aorta was isolated, and cut into small pieces (1 × 1 mm)
in phosphate buffered saline (PBS). Ten to fifteen pieces
of tissue were suspended in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10 % fetal bovine
serum (FBS) and antibiotics. After four to five days,
SMCs began to proliferate from the tissue margin. Dermal
fibroblasts (DFBs) were isolated from ventral skin explants
as described previously [9].
Third passage cells were employed for cell sheet trans-
plantation and in vitro studies. To prepare cell sheets,
cells were cultured on 35-mm temperature-responsive
culture dishes (UpCell, CellSeed Inc., Tokyo, Japan) at
37 °C in a humidified atmosphere containing 5 % CO2.
To trace the cells of the transplanted cell sheets,
monolayer cell sheets were stained with PKH26 red
fluorescent cell linker kit (Sigma-Aldrich Co. St. Louis,
MO) for 5 min before cell seeding. After seven days,
the cultured cells were transferred to 20 °C for one
hour to release the cultured cells as intact sheets
(Fig. 1-a). Cell sheet shrinks into about 15-mm diameter
(Fig. 1-b, c).
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Transplantation of cell sheets
Surgical mortality of MI operation was 9.1 % (3 of 33
rats), and seven days after coronary ligation, survived 30
rats were randomly divided into 3 treatment groups: (1)
SMC sheet transplant (SMC-Tx group, n = 10); (2) DFB
sheet transplant (DFB-Tx group, n = 10); (3) no cell sheet
transplantation (Untreated group, n = 10). Rats were
anesthetized with Isoflurane and the heart was exposed
through a median sternotomy. The monolayered cell
graft was placed on a plastic sheet and applied face
down onto the surface of the anterior scar (Fig. 1-b, c).
The plastic sheet was then carefully removed, leaving
the monolayered cell graft on the surface of the heart.
Ten minutes after transplantation, the chest was closed
and the animals were treated in the same manner as
described after LAD ligation. The Untreated and Sham
(without MI, n = 10) groups underwent the same opera-
tive procedures without cell grafting. There was no
death after cell sheet transplantation in each group.
Measurements of cardiac function
Cardiac function in the SMC-Tx, DFB-Tx and untreated
groups was evaluated with echocardiography six days after
LAD ligation prior to sheet transplantation (baseline) and
twenty-eight days after cell sheet transplantation. The rats
(n = 10 rats per group) were sedated with Isoflurane, and
left parasternal images were taken in the right lateral
decubitus position with a 12-MHz transducer (LOGIQ
P5J and 12 L, respectively, GE Healthcare, Fairfield, CT).
Short-axis two-dimensional images at the midpapillary
level of the left ventricle were stored as digital loops,
and the end-systolic (ESA) and end-diastolic (EDA)
cavity areas and dimensions were determined by tracing
the endocardial borders. The fractional area shortening
(FAS) was calculated as (EDA - ESA)/EDA × 100. The
ejection fraction (EF) was calculated using Teichholz
equation. For each measurement, three consecutive car-
diac cycles were traced and averaged by an experienced
examiner in a blinded fashion, according to the American
Society for Echocardiology Leading Edge Method.
In vitro measurements of angiogenic factor secretion
In MI, the occlusion of a coronary artery blocks the oxy-
gen and nutrient supply to the myocardium it supplied,
and causes severe stress as well as cell death. Trans-
planted cells face the same severe surroundings. SMCs
or DFBs (n = 5 per each groups) were seeded on 35 mm
dishes and were incubated for four days. Cells were then
incubated in normal (37 °C, 5 % CO2) or hypoxic con-
ditions for forty-eight hours with 10 % FBS DMEM.
Hypoxic conditions (<2 % O2) were prepared using a
Gaspak system (Becton Dickinson, Bedford, MA). The
hypoxic condition was verified by the color of anaerobic
indicator which was inside the jar in all experiments.
Enzyme-linked immunosorbent assay kits for rat VEGF
(Quantikine, R&D, Minneapolis, MN), human bFGF (R&D)
and rat HGF (Institute of Immunology, Osaka, Japan)
were used according to the manufacturer’s protocols.
Flowcytometric analysis
Numbers of SMCs isolated from aorta were measured by
flowcytometer using anti-α smooth muscle actin antibody
(Sigma-Aldrich Co. St. Louis, MO), and PE-conjugated
anti-mouse IgG (Becton Dickinson, Bedford, MA). And
98 % of the isolated cell was positive for smooth cell
marker (data not shown).
In vitro apoptosis assay
SMCs or DFBs (n = 5 per each groups) were seeded on
35 mm dishes and were incubated for four days. Cell were
then incubated in hypoxic conditions using a Gaspak sys-
tem for forty-eight hours with 10 % FBS DMEM. Cells
were then detached with trypsin and apoptotic cell num-
bers were measured by flow cytometry (ApoAlert Annexin
V-FITC Apoptosis Kit, Clontech, Mountain View, CA).
Planimetric analysis of ventricular morphology
At twenty-eight days after cell sheet transplantation,
formalin-fixed hearts (n = 5 rats per group) were cut into
2-mm-thick sections, and quantified using digital image
analysis (Adobe Photoshop, Adobe Systems Inc., San




Fig. 1 Representative pictures of cell sheet harvesting and transplantation.
a; Cell sheet which was completely removed from temperature-responsive
culture dish (35-mm diameter). Cell sheet shrinks into about 15-mm
diameter. Scale bar = 10 mm. b; Cell sheet was put on a plastic sheet
before transplantation. c; The cell sheet was applied face down onto
the surface of the anterior scar. The plastic sheet was then carefully
removed, leaving the monolayered cell sheet on the surface of the heart
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chamber volume was calculated from planimetric mea-
surements. The thickness of the left ventricular free wall
and the scar area were also measured. Briefly, hearts
were fixed at a ventricular pressure of 30 mmHg with
10 % phosphate-buffered formalin solution for forty-eight
hours. The formalin fixed hearts were cut into 2-mm-
thick sections and paraffin embedded. Sections were then
stained with Van Gieson staining, and each section were
digitally photographed. The area of the left ventricular
chamber and length of scar were measured in each sec-
tion. The ventricular area and scar length was multiplied
by the 2 mm thickness of each section, and the sum of all
sections was calculated as the left ventricular chamber
volume and scar area.
Histological examination
At twenty-eight days after cell sheet transplantation, the
LV myocardium (n = 5 from each group) was fixed in
10 % formalin, cut transversely, embedded in OCT com-
pound (Tissue-Tek, Sakura Finetek Japan Co., Ltd, Tokyo,
Japan), sliced (10 μm thickness) and stained.
To detect interstitial fibrosis in cardiac muscle, speci-
mens were stained with van Gieson. Transverse sections
were obtained from the 3 parts (lateral, posterior, and
septum). Three randomly selected fields per section (n = 9
per animal) were analyzed at a magnification of 100x
(Eclipse-TE200, Nikon, Tokyo, Japan). Each field was
scanned and digital images were analyzed (Adobe Photo-
shop and ImageJ). Collagen composition (red staining)
was calculated as the sum of all areas containing connective
tissue divided by the total area of the image.
To measure the ratio of preserved myocardium in the
risk area, transverse sections were obtained and photo-
graphed. The risk area was composed of the elastic fiber
depicted by blue signal, scar depicted by red signal and
preserved myocardium depicted yellow signal, in Fig. 3-a.
We defined the proportion of preserved myocardium in
the risk area as the ratio of area depicting yellow signal in
the risk area of myocardial infarction. The total area at risk
(scar area) and preserved myocardium were scanned and
digitally analyzed; the ratio was calculated as (total area of
preserved myocardium/total area of risk area) × 100.
To detect microvessels characterized by α-smooth
muscle actin (α-SMA) in the border-zone of myocardium
and scar, immunohistochemical staining was performed
with a monoclonal antibody against α-SMA. Transverse
sections were obtained, and 5 of 10 randomly selected
fields per animal were analyzed. The number of vessels
was counted by light microscopy at a magnification of
200x. The number of arterioles in each field was averaged
and expressed as the number of arteriole vessels.
These studies were performed by 2 examiners who
were blinded to the sample groups.
In vivo apoptosis assay
Forty-eight hours after cell sheet transplantation, the
number of grafted sheets containing fragmented DNA in
the SMC-Tx and DFB-Tx groups (n = 5 rats per group) was
detected by in situ terminal deoxynucleotidyl transferase-
mediated dUTP nick-end labeling (TUNEL) assay using an
in situ cell death detection kit according to the manufac-
turer’s instructions (TACS-XL in situ Apoptosis Detection
Kit, TREVIGEN, Gaithersburg, MD). The sample sections
were counterstained with Methyl Green. Three micro-
scopic fields (at 200x) of each slide were randomly selected
and digitally photographed. To identify the grafted sheets,
the sections adjacent to the section used for TUNEL
staining were also prestained with the PKH before
transplantation. The number of grafted and apoptotic
cells were counted separately with digital image analysis
(Adobe Photoshop, Adobe Systems Inc., San Jose, CA,
and Image J, NIH, MD). Apoptosis was expressed as
the number of apoptotic grafted nuclei per field.
Measurements of cell sheet strength
To measure cell sheet strength, we used a custom-made
apparatus. In a water bath perfused with 37 °C physio-
logical saline, SMC and DFB sheets (n = 3 per groups)
were affixed to a table made from acrylic resin containing
a 6 mm hole. Small weights were placed on the cell
sheets and digital images were taken. Images were col-
lected at increasing weights (5 – 10 – 20 – 30 – 50 –
100 – 200 – 300 mg), and the maximum tolerance weight
was recorded. Additionally, cell sheet displacement was
measured (Fig. 6).
Data analysis
All data are expressed as mean ± SE. One-way analysis
of variance (ANOVA) was used for multiple group com-
parisons. If the F-distribution was significant, a Tukey’s
test was used to specify differences between groups. A
probability value of < 0.05 was considered significant.
Results
Cardiac function: echocardiography
The final cell counts for monolayered SMCs and DFBs
before transplantation were 3.1 ± 0.2 × 106 and 1.5 ±
0.9 × 106 cells, respectively (n = 6 each). There was no
difference among the three groups in the FAS and EF
prior to cell sheet transplantation. Twenty-eight days
after cell sheet transplantation, we found a significantly
greater FAS in the SMC-Tx group (32.3 ± 2.1 %) com-
pared to the other groups (DFB-Tx, 23.3 ± 2.1 %; un-
treated, 25.1 ± 2.6 %). Also, we found a significantly
greater EF in the SMC-Tx group (40.8 ± 2.0 %) compared
to the other groups (DFB-Tx, 33.7 ± 1.2 %; untreated,
35.5 ± 1.0 %). There was no significant difference in the
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FAS and EF between the DFB-Tx and untreated groups
(Fig. 2).
Ventricular morphology
Morphological assessments of the left ventricle are
summarized in Table 1. At twenty-eight days after
transplantation, left ventricular volume was signifi-
cantly smaller (p < 0.05) in the SMC-Tx group com-
pared to the DFB-Tx and untreated groups. Similarly,
the scar area was significantly (p < 0.05) smaller in the
SMC-Tx group than in the other groups. Furthermore,
wall thickness in the scar area and posterior wall were
significantly greater (p < 0.05) in the SMC-Tx group,
compared to the other groups.
Histological findings
Twenty-eight days after treatment, Van Gieson staining
revealed significantly less fibrosis in the SMC-Tx group
than in the other groups (Table 1). Additionally, the
SMC-Tx group showed more preserved myocardium in
the risk area compared to the other groups (Fig. 3-a, b).
In the SMC-Tx group, there were a greater number of
mature vessels in the border-zone compared to the
DFB-Tx and untreated groups (Fig. 3-c, d).
Forty-eight hours after cell sheet transplantation, SMC
and DFB sheets were confirmed to exist on the infarcted
areas as layers (Fig. 4-a, b). Twenty-eight days after
transplantation, SMC sheets existed on the scar as a
layer (Fig. 4-d). In contrast, DFB sheets were scattered
(Fig. 4-e). There was no red fluorescence in the un-
treated group at both forty-eight hours and twenty-eight
days after transplantation (Fig. 4-c, f ).
We observed whether PKH26-fluorescent marker posi-
tive cells migrate into the ischemic zone in all the samples.
However, no migrated cell was detected in our observation.
Cell survival in vitro and in vivo
The number of apoptotic cells was significantly lower in
hypoxic SMCs (1.7 ± 0.2 %) compared to DFBs (9.6 ±
0.8 %) in vitro (Fig. 5-c). Additionally, TUNEL-positive
SMCs were rarely detected (0.9 ± 0.3cells/HPF) in the
sheets 48 h after transplantation. In contrast, TUNEL-
positive DFBs were frequently detected (3.7 ± 0.6cells/
HPF) in the DFB sheets (Fig. 4-g, h, i).
Cell sheet strength
SMC sheets showed significantly less sinking distance
with the 5 mg weight than DFB sheets (SMC sheet,
0.96 ± 0.06 mm; DFB sheet, 2.77 ± 0.12 mm, p < 0.05)
(Fig. 6-b, c, e). Similarly, SMC sheets showed signifi-
cantly higher maximum weight tolerance (266.7 ±
33.3 mg) compared to DFB sheets (6.7 ± 1.7 mg, p < 0.05)
(Fig. 6-d, f ).
Secretion of angiogenic factors
bFGF production in SMCs and DFBs cultured in nor-
moxic conditions were very low and comparable; how-
ever, bFGF significantly increased in SMC (normoxia,
1.3 ± 0.5 pg/ml; hypoxia, 157.7 ± 6.4 pg/ml) but not DFB
(normoxia, 3.6 ± 0.5 pg/ml; hypoxia, 3.1 ± 1.0 pg/ml) cul-
tured in hypoxia (Fig. 5-a). In contrast, DFBs secreted
about four-fold higher VEGF in hypoxic conditions
(4112 ± 114 pg/ml), and about nine-fold higher VEGF in
normoxic conditions (5857 ± 418 pg/ml) than SMCs
(normoxia, 665 ± 33 pg/ml; hypoxia, 1029 ± 148 pg/ml)
Fig. 2 Fractional area shortening (Panel a) and ejection fraction
(Panel b) assessed by echocardiography in experimental groups
before cell sheet transplantation (baseline) and twenty-eight days
after cell sheet transplantation (after treatment). *p < 0.05 vs. SMC-Tx.
SMC-Tx, smooth muscle cell sheet transplantation group; DFB-Tx,
dermal fibroblast sheet transplantation group; Untreated, untreated
group. Each groups n = 10
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(Fig. 5-b). HGF were not detected in normoxic and hyp-
oxic conditions in both SMC and DFB culture medium.
Discussion
Our results indicate that SMC sheet transplantation pre-
served cardiac function and prevented cardiac remodeling
compared to DFB sheet transplantation. These effects cor-
related with the prevention of hypoxia-induced apoptosis,
production of bFGF, and increased mechanical support of
the infarcted myocardium in a rat MI model. To the best
of our knowledge, this is the first report that investigated
the effect of SMC sheet transplantation in a rat MI model.
To escape from cell death and dysfunction in ischemic
condition, blood perfusion recovery and obtain the toler-
ance against ischemia may deal effectively. In hypoxic
conditions, SMCs showed a significantly lower number
Table 1 Ventricular morphology and fibrosis
Group LV volume (mm3) Scar area (mm2) Scar thickness (mm) PW thickness (mm) Fibrosis (%)
Sham 335.1 ± 16.5 – – 1.87 ± 0.09 1.26 ± 0.16
SMC-Tx 402.9 ± 5.5* 49.4 ± 2.3 1.09 ± 0.05 1.85 ± 0.04 0.87 ± 0.18
DFB-Tx 497.0 ± 24.2*,** 83.1 ± 7.4** 0.89 ± 0.05** 1.57 ± 0.06*,** 2.33 ± 0.26*,**
Untreated 489.9 ± 18.7*,** 86.6 ± 11.8** 0.76 ± 0.06** 1.46 ± 0.07*,** 2.22 ± 0.35*,**
Summary of LV morphological data by planimetry and fibrosis of non-infarcted myocardium collected for each group at twenty-eight days after cell sheet trans-
plantation.
LV left ventricular, PW posterior wall, SMC-Tx smooth muscle cell sheet transplantation group, DFB-Tx dermal fibroblast sheet transplantation group, Untreated, un-
treated group. Each groups n = 5.
*p<0.05 vs. Sham, **p<0.05 vs. SMC-Tx.
Fig. 3 Representative pictures of myocardium (a, shown by #) in the scar area of SMC-Tx, DFB-Tx and untreated. b; % myocardium in the risk area
was significantly higher in SMC-Tx. c; Representative pictures of α-SMA+ arterioles in border-zone between myocardium and scar area. Upper panels
are less magnified pictures of border-zone, and lower panels are higher magnified pictures of border-zone. Scale bar = 100 μm. D; α-SMA+ arterioles in
border-zone were significantly increased in SMC-Tx. *p < 0.05 vs. SMC-Tx; †p < 0.05 vs. other groups. SMC-Tx, smooth muscle cell sheet transplantation
group; DFB-Tx, dermal fibroblast sheet transplantation group; Untreated, untreated group. Each groups n = 5
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Fig. 4 Confirmation of the attachment of transplanted cell sheet at forty-eight hours (a–c) and twenty-eight days (d–f) after transplantation. Left
panels are SMC-Tx (a, d), middle panels are DFB-Tx (b, e), and right panels are Untreated (c, f). Red signal, PKH stained cell sheet; blue signal, DAPI
for nuclear staining. Microphotographs of transplanted cell sheet forty-eight hours after transplantation that has been stained with TUNEL assay in
SMC-Tx (g) and DFB-Tx (h) groups. Numbers of TUNEL-positive grafted cell sheets (i). *p < 0.01 vs. SMC-Tx. Each groups n = 5. Scale bar = 500 μm
(a–f), 50 μm (g, h). SMC-Tx, smooth muscle cell sheet transplantation group; DFB-Tx, dermal fibroblast sheet transplantation group; Untreated,
untreated group
Fig. 5 Angiogenic factor secretion under normal and hypoxic condition in vitro. a; bFGF. b; VEGF. c; Apoptosis assay of cells cultured in vitro in
hypoxic conditions. *p < 0.01 vs. SMC. Each groups n = 5
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of apoptotic cells than DFBs in vitro (Fig. 5-c). Addition-
ally, forty-eight hours after transplantation post MI we
observed less apoptotic cells in the SMC-Tx group com-
pared to the DFB-Tx group (Fig. 4-g, h, i) in vivo. Be-
cause SMCs have a higher tolerance for ischemia and
hypoxia, SMC sheets may be able to survive on the scar
as an attached layer (Fig. 4-d) at twenty-eight days after
transplantation. In contrast, DFB sheets could not sur-
vive in vivo. It has been reported that preventing apop-
tosis of transplanted cells can increase cell survival and
ventricular function [17], and loss of transplanted cell
leads to deterioration of cardiac function in a mouse
model [5]. These concepts suggest that the superior sur-
vival rate of transplanted cells is essential for cell therapy.
It is known that bFGF stimulates the maturation of
vasculature, which are lined with vascular smooth muscle
cells. These vessels could provide long-term stable
perfusion [19]. SMCs secreted significantly higher amounts
of bFGF in hypoxic conditions compared to SMCs in
normoxia and hypoxic DFBs (Fig. 5-a). Our data suggest
that bFGF secreted by SMC sheets increased arteriole
number in the border-zone between healthy myocardium
and the scar areas (Fig. 3-c, d), which was consistent with
previous report [20, 21] and maintained viable myocardium
in the scar area (Fig. 3-a, b). In contrast, DFBs secreted a
higher amount of VEGF than SMCs in hypoxic and
normoxic conditions (Fig. 5-b). VEGF is widely known as
one of the critical factors in promoting angiogenesis [20];
however, DFB sheets did not improve cardiac function [9].
Our data suggest that DFB sheets could not survive hypoxia
and thus could not produce sufficient amounts and
duration of VEGF to rescue cardiomyocytes althoughVEGF
could be a more potent angiogenic factor than bFGF. Thus,
we considered that the higher tolerance of SMC sheets to
Fig. 6 Representative schema of custom-made apparatus to measure cell sheet strength (a). Cell sheets were stretched by weights and photographed.
“Sinking Distance” was then measured (blue arrow). Representative pictures of stretched cell sheet by weight loading to measure cell sheet strength
(b–d). SMC sheet at 5 mg (b), DFB sheet at 5 mg weight (c) and SMC sheet at 200 mg (d). “Sinking Distance” was measured as a distance within
red bars and red arrows (yellow bicephalic arrows). Scale bar (white bar) = 5 mm. Sinking distance at 5 mg (e) and maximum weight tolerance (f) was
measured. *p < 0.05 vs. DFB sheet. SMC, smooth muscle cell; DFB, dermal fibroblast. Each groups n = 3
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hypoxia enables them to survive longer after transplant-
ation. Furthermore, the long-term secretion of bFGF by
transplanted SMC sheets might contribute to maintain
arterioles and may support the survival of the SMC sheet
cells and the myocardium in the late phases. One possible
explanation is that SMCs are secreting more potent angio-
genic factor than VEGF, which we did not evaluate. The
other possibility is that the paracrine effect of SMCs last
longer although the angiogenic effect itself is inferior.
SMC sheet transplantation preserved scar thickness in
vivo (Table 1). Preserving scar thickness is very import-
ant to reduce wall stress [9, 22] and prevent ventricular
dilatation. Additionally, cardiac support devices, which
are designed as mesh-like implantable devices that are
surgically positioned around the heart and adjusted to
provide circumferential diastolic support and prevent
ventricular dilatation, have been used [23, 24]. Because
SMC sheets showed significantly higher weight tolerance
than DFB sheets (Fig. 6), we considered that SMC sheets
contributed mechanical support to prevent scar thinning
and expansion in the weakened myocardium. On the
other hand, it is expected that using artificial materials
as a patch may contribute to reinforcement; however, it
is difficult to uniformly attach the artificial materials
onto the scar. In contrast, attachment of biological tissue
onto the scar is feasible, and the secretion of angiogenic
factors has been reported [8, 9, 25]. For these reasons we
considered that transplantation of the SMC sheet could be
a promising candidate for future clinical applications.
Cell sheet transplantation of skeletal myoblasts was
reported to have advantages over cell injection methods
in MI and DCM models [8, 26, 27]. Cell sheet technol-
ogy enables the transplantation of cells with more
physiological conditions, and the cell loss compared with
direct cell injection is lower. Similar properties could be
expected with SMC sheets [13]. Cell sheet technology
has been investigated not only in heart failure, but also
in the treatment of other organ dysfunctions, such as
cornea [28], periodontal ligament [29], oral mucosa [30] and
urothelium [31]; therefore future development is expected.
We investigated only up to thirty-five days after MI;
however, investigation for much longer periods will be
required before the clinical application of SMC sheets
can be conducted. The feasibility of SMC sheets may be
controversial; however, our data support beneficial effects.
Further technical advances are expected using embryonic
stem cells and induced pluripotent stem cells in the near
future; therefore these technologies might help investiga-
tors to supply many different cell sources.
Conclusions
SMC sheets contribute to cardiac function and attenuate
cardiac remodeling with sufficient effects of angiogenic
factors which are brought through superior cell survival.
Additionally, SMC sheets seem to contribute to cardiac
function by serving as mechanical support for the in-
farcted myocardium. These results indicate that this
method may be a new strategy for ischemic cardiomyop-
athy therapy.
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